Stock listing

A1J84E Stock Price, News, Filings & Events — Abbvie Inc.

Selected listing: A1J84E · LSX · EUR · DE

This page tracks Abbvie Inc.'s A1J84E:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1J84E:LSX. A1J84E:LSX is the stock-level entry point for investors researching Abbvie Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Abbvie Inc. (ticker: ABBV) is a publicly traded company based in the United States, with a market capitalization of approximately $458.24 billion. The company is involved in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies. Abbvie aims to address complex health challenges and improve patient outcomes through its diverse portfolio of products.

A1J84E:LSXEURDEUpdated August 14, 2026
Abbvie Inc. logo
Ticker
A1J84E:LSX
Asset type
Stock
Market cap
$440.83B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LSX
Currency
EUR

Abbvie Inc. A1J84E:LSX stock context

This page tracks Abbvie Inc.'s A1J84E:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1J84E:LSX. A1J84E:LSX is the stock-level entry point for investors researching Abbvie Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Abbvie Inc. (ticker: ABBV) is a publicly traded company based in the United States, with a market capitalization of approximately $458.24 billion. The company is involved in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies. Abbvie aims to address complex health challenges and improve patient outcomes through its diverse portfolio of products.

Research Abbvie Inc.

Alternate listings